- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 48.86M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 49.25M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 48.37M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $167K |
| Capex | Q1 2026 · Mar 31, 2025 | $175K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$491K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $1.73M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $2.5M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $5M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $22.82M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $33.04M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $372.23M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $371.89M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $352.62M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $348.91M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $18.25M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $22.98M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $28.68M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $34M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $133.22M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $136.56M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $400.91M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $405.88M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.02 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.01 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $12.21M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $11.35M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $2.65M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $1.44M |
| Net Income | Q1 2026 · Mar 31, 2026 | $1.19M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$448K |
| Operating Income | Q1 2026 · Mar 31, 2026 | $27K |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$499K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $17.5M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $14.8M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $10M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $7.25M |